Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 3 | 9 |
| List of Tables | 6 | 3 |
| List of Figures | 9 | 3 |
| Clinical Trial Recruitment in Autoimmune Disorders- Introduction | 12 | 2 |
| GBI Research Report Guidance | 12 | 2 |
| Clinical Trial and Patient Recruitment - Overview | 14 | 3 |
| Effect of Clinical Trial Study Design on Patient Recruitment | 14 | 1 |
| Types of Study Designs | 14 | 1 |
| Current Challenges in Clinical Trial Recruitment and Enrollment | 15 | 1 |
| Challenges in Clinical Trials Due to Stringent Inclusive and Exclusive Criteria | 15 | 1 |
| Lack of Awareness of Appropriate Clinical Trials | 15 | 1 |
| Knowledge about Regulations | 15 | 1 |
| Required Infrastructure | 15 | 1 |
| Belief in Doctors and the Patients that Standard Therapy is Best | 16 | 1 |
| Challenges in Clinical Research- Volunteer Perspective | 16 | 1 |
| Lack of Access to Trials | 16 | 1 |
| Fear, Distrust or Suspicions of Research | 16 | 1 |
| Practical or Personal Obstacles | 16 | 1 |
| Insurance and Financial Problems | 16 | 1 |
| Long-standing Fear, Apprehension and Disbelief | 16 | 1 |
| Clinical Trial Recruitment in Autoimmune Disorders - Overview | 17 | 4 |
| Clinical Trial Share by Therapeutic Area | 17 | 1 |
| Clinical Trials for the Five Major Indications in Autoimmune Disorders | 18 | 1 |
| Patient Recruitment for the Five Major Indications in Autoimmune Disorders | 19 | 1 |
| Major Indications in Autoimmune Disorders | 20 | 1 |
| Clinical Trials and Patient Recruitment for Multiple Sclerosis | 21 | 15 |
| Multiple Sclerosis- Overview | 21 | 2 |
| Clinical Trials for Multiple Sclerosis | 23 | 1 |
| Number of Clinical Trials by Stage of Development | 23 | 1 |
| Number of Clinical Trials by Sponsor | 24 | 1 |
| Number of Clinical Trials by Geography | 25 | 1 |
| Number of Clinical Trials per Year | 26 | 1 |
| Patient Recruitment for Multiple Sclerosis | 27 | 1 |
| Number of Patients Recruited by Stage of Development | 27 | 1 |
| Number of Patients Recruited by Sponsor | 28 | 1 |
| Number of Patients Recruited by Geography | 29 | 1 |
| Number of Patients Recruited per Year | 30 | 1 |
| Average Number of Patients Recruited per Trial | 31 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 31 | 1 |
| Average Number of Patients Recruited per Trial per Year | 32 | 1 |
| Prevalence Population for Multiple Sclerosis in Brazil, China and India | 33 | 1 |
| Prevalence Population for Multiple Sclerosis in Brazil (2010-2017) | 33 | 1 |
| Prevalence Population for Multiple Sclerosis in China (2010-2017) | 34 | 1 |
| Prevalence Population for Multiple Sclerosis India (2010-2017) | 35 | 1 |
| Clinical Trials and Patient Recruitment for Rheumatoid Arthritis | 36 | 14 |
| Rheumatoid Arthritis- Overview | 36 | 1 |
| Clinical Trials for Rheumatoid Arthritis | 37 | 1 |
| Number of Clinical Trials by Stage of Development | 37 | 1 |
| Number of Clinical Trials by Sponsor | 38 | 1 |
| Number of Clinical Trials by Geography | 39 | 1 |
| Number of Clinical Trials by Year | 40 | 1 |
| Patient Recruitment for Rheumatoid Arthritis | 41 | 1 |
| Number of Patients Recruited by Stage of Development | 41 | 1 |
| Number of Patients Recruited by Sponsor | 42 | 1 |
| Number of Patients Recruited by Geography | 43 | 1 |
| Number of Patients Recruited by Year | 44 | 1 |
| Average Number of Patients Recruited per Trial | 45 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 45 | 1 |
| Average Number of Patients Recruited per Trial per Year | 46 | 1 |
| Prevalence Population for Rheumatoid Arthritis in Brazil, China and India | 47 | 1 |
| Prevalence Population for Rheumatoid Arthritis in Brazil (2010-2017) | 47 | 1 |
| Prevalence Population for Rheumatoid Arthritis in China (2010-2017) | 48 | 1 |
| Prevalence Population for Rheumatoid Arthritis India (2010-2017) | 49 | 1 |
| Clinical Trials and Patient Recruitment for Crohn s Disease | 50 | 14 |
| Crohn s Disease- Overview | 50 | 1 |
| Clinical Trials for Crohn s Disease | 51 | 1 |
| Number of Clinical Trials by Stage of Development | 51 | 1 |
| Number of Clinical Trials by Sponsor | 52 | 1 |
| Number of Clinical Trials by Geography | 53 | 1 |
| Number of Clinical Trials by Year | 54 | 1 |
| Patient Recruitment for Crohn s Disease | 55 | 1 |
| Number of Patients Recruited by Stage of Development | 55 | 1 |
| Number of Patients Recruited by Sponsor | 56 | 1 |
| Number of Patients Recruited by Geography | 57 | 1 |
| Number of Patients Recruited by Year | 58 | 1 |
| Average Number of Patients Recruited per Trial | 59 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 59 | 1 |
| Average Number of Patients Recruited per Trial per Year | 60 | 1 |
| Prevalence Population for Crohn s Disease in Brazil, China and India | 61 | 1 |
| Prevalence Population for Crohn s Disease in Brazil (2010-2017) | 61 | 1 |
| Prevalence Population for Crohn s Disease in China (2010-2017) | 62 | 1 |
| Prevalence Population for Crohn s Disease India (2010-2017) | 63 | 1 |
| Clinical Trials and Patient Recruitment for Ulcerative Colitis | 64 | 14 |
| Ulcerative Colitis- Overview | 64 | 1 |
| Clinical Trials for Ulcerative Colitis | 65 | 1 |
| Number of Clinical Trials by Stage of Development | 65 | 1 |
| Number of Clinical Trials by Sponsor | 66 | 1 |
| Number of Clinical Trials by Geography | 67 | 1 |
| Number of Clinical Trials by Year | 68 | 1 |
| Patient Recruitment for Ulcerative Colitis | 69 | 1 |
| Number of Patients Recruited by Stage of Development | 69 | 1 |
| Number of Patients Recruited by Sponsor | 70 | 1 |
| Number of Patients Recruited by Geography | 71 | 1 |
| Number of Patients Recruited by Year | 72 | 1 |
| Average Number of Patients Recruited per Trial | 73 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 73 | 1 |
| Average Number of Patients Recruited per Trial per Year | 74 | 1 |
| Prevalence Population for Ulcerative Colitis in Brazil, China and India | 75 | 1 |
| Prevalence Population for Ulcerative Colitis in Brazil (2010-2017) | 75 | 1 |
| Prevalence Population for Ulcerative Colitis in China (2010-2017) | 76 | 1 |
| Prevalence Population for Ulcerative Colitis India (2010-2017) | 77 | 1 |
| Clinical Trials and Patient Recruitment for Psoriasis | 78 | 14 |
| Psoriasis- Overview | 78 | 1 |
| Clinical Trials for Psoriasis | 79 | 1 |
| Number of Clinical Trials by Stage of Development | 79 | 1 |
| Number of Clinical Trials by Sponsor | 80 | 1 |
| Number of Clinical Trials by Geography | 81 | 1 |
| Number of Clinical Trials by Year | 82 | 1 |
| Patient Recruitment for Psoriasis | 83 | 1 |
| Number of Patients Recruited by Stage of Development | 83 | 1 |
| Number of Patients Recruited by Sponsor | 84 | 1 |
| Number of Patients Recruited by Geography | 85 | 1 |
| Number of Patients Recruited by Year | 86 | 1 |
| Average Number of Patients Recruited per Trial | 87 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 87 | 1 |
| Average Number of Patients Recruited per Trial per Year | 88 | 1 |
| Prevalence Population for Psoriasis in Brazil, China and India | 89 | 1 |
| Prevalence Population for Psoriasis in Brazil (2010-2017) | 89 | 1 |
| Prevalence Population for Psoriasis in China (2010-2017) | 90 | 1 |
| Prevalence Population for Psoriasis India (2010-2017) | 91 | 1 |
| Appendix | 92 | 4 |
| Market Definitions | 92 | 1 |
| Abbreviations | 92 | 1 |
| Research Methodology | 92 | 3 |
| Clinical Trials Overview | 93 | 1 |
| Number of Clinical Trials | 93 | 1 |
| Patient Recruitment Status | 93 | 1 |
| Prevalence of Disease in India, China and Brazil (2010-2017) | 93 | 1 |
| Primary Research | 94 | 1 |
| Expert Panel Validation | 94 | 1 |
| Contact Us | 94 | 1 |
| Disclaimer | 94 | 1 |
| Sources | 95 | 1 |